Closing arguments concluded before Memorial Day weekend in an Actos bladder cancer lawsuit in a Nevada state court in Las Vegas. The plaintiffs in the case filed their lawsuit targeted…
Carey Danis LoweMay 29, 2014
Carey Danis & Lowe Actos lawyers were optimistic last week when plaintiff Jack Cooper received a compensatory award in the amount of $6.5 million. However, it appears that California Superior…
Carey Danis LoweMay 22, 2013
Takeda Pharmaceuticals, the Japanese pharmaceutical giant responsible for the development and marketing of the diabetes drug Actos, concealed the association between Actos and bladder cancer, a jury was recently told…
Carey Danis LoweMay 17, 2013
A California jury recently awarded a compensatory package of $6.5 million to a plaintiff in an Actos bladder cancer lawsuit. The case, Cooper v. Takeda, was heard over a two…
Carey Danis LoweMay 8, 2013
Testimony provided in late March by a urologist in an Actos trial taking place in a Los Angeles court presented an expert's opinion about the link between Actos and bladder…
Carey Danis LoweApril 13, 2013
The first trial in more than 3,000 Actos lawsuits filed in the U.S. is currently being heard in a Los Angeles court. Lawyers at Carey Danis & Lowe reported last…
Carey Danis LoweMarch 8, 2013
In 2003, Takeda Pharmaceuticals Inc. expressed concerns about whether Actos users could develop cancer. These reservations on the part of the Japanese pharmaceutical company came to light in court documents…
Carey Danis LoweFebruary 27, 2013
The first Actos lawsuit has gone to trial in a California Superior Court in Los Angeles, known as Cooper v. Takeda Pharmaceuticals America Inc. Cooper v. Takeda is being heard…
Carey Danis LoweFebruary 26, 2013
The manufacturer of the diabetes drug Actos, a drug that is tied up in mounting complaints and lawsuits citing the development of bladder cancer, has received U.S. Food and Drug…
Carey Danis LoweFebruary 8, 2013